Apollo Ventures

Apollo Ventures

A venture capital firm in Germany that focuses on assets that treat, prevent, or even reverse age-related diseases such as alzheimer's, heart disease, sarcopenia, frailty, and cancer, with the goal of increasing healthy human lifespan.

Apollo Ventures is a venture capital firm in Germany that focuses on assets that treat, prevent, or even reverse age-related diseases such as alzheimer's, heart disease, sarcopenia, frailty, and cancer, with the goal of increasing healthy human lifespan. Founded 2016 in Hamburg, Germany by James Peyer, Nils Regge and Ole Mensching, and this venture capital firm invests in early stage ventures and seed. Its portfolio companies include Aeovian Pharmaceuticals, Samsara Therapeutics and Cleara Biotech. As of February 2020, Apollo Ventures has made four investments. Their most recent investment was on October 3, 2019, when Aeovian Pharmaceuticals raised $37M.

Timeline

2016

Founded

Funded Companies

Company
Website
Industry
Location
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Dr. Steven Leunert

CFO

Dr. Victor Pavlenko

Venture Developer

James Peyer

Co-founder

James Peyer, PhD

Founder

Jens Eckstein, PhD

Managing Partner

Nils Regge

Co-Founder & Managing Director

Ole Mensching, PhD

Co-Founder & Head of HR

Victor Bustos, PhD

Venture Analyst

Further reading

Title
Author
Link
Type
Date

This Scientist-Turned-VC Wants to Extend Life - NEO.LIFE - Medium

Karen Weintraub

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Aeovian Pharmaceuticals

Cleara Biotech

Samsara Therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.